BIOREGENX, INC.
BRGX · OTCMCIK 1593184fmd_1SE3B4EV3RQ0J0JKK3X6YZWB9KServices · Services-Computer Programming, Data Processing, Etc.Template: Standard
Coverage: Jan 01, 2021 to Mar 31, 2026, 18 periods
Latest annual · FY2025
Millions- Total revenues
- 2
- Gross profit
- 2
- Operating income
- (1)
- Net income
- (2)
- Free cash flow
- 0
Latest quarter · Q1 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
- Free cash flow
- 0
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +253.0%
BIOREGENX, INC. (BRGX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.9 million | $2.3 million | -20.8% | 10-K 2026-04-15 · proof |
| Gross profit | $1.5 million | $1.7 million | -9.3% | 10-K 2026-04-15 · proof |
| Operating income | -$1.2 million | -$22.8 million | 10-K 2026-04-15 · proof | |
| Net income | -$1.5 million | -$23.1 million | 10-K 2026-04-15 · proof | |
| Cash from operating activities | $38,972 | -$324,148 | 10-K 2026-04-15 · proof | |
| Free cash flow | $29,915 | -$513,538 | 10-K 2026-04-15 · proof | |
| Total assets | $410,986 | $508,535 | -19.2% | 10-K 2026-04-15 · proof |
| Total liabilities | $4.9 million | $3.9 million | +27.3% | 10-K 2026-04-15 · proof |
| Cash and cash equivalents | $69,383 | $58,404 | +18.8% | 10-K 2026-04-15 · proof |
| Total debt | $1.2 million | $1.1 million | +4.1% | 10-K 2026-04-15 · proof |
- What was BIOREGENX, INC. (BRGX)'s revenue in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported revenue of $1.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $2.3 million the year before (-20.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOREGENX, INC. (BRGX)'s gross profit in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported gross profit of $1.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $1.7 million the year before (-9.3%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOREGENX, INC. (BRGX)'s operating income in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported operating income of -$1.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$22.8 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOREGENX, INC. (BRGX)'s net income in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported net income of -$1.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$23.1 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOREGENX, INC. (BRGX)'s cash from operating activities in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported cash from operating activities of $38,972 for fiscal 2025 (the year ended Dec 31, 2025), against -$324,148 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was BIOREGENX, INC. (BRGX)'s free cash flow in fiscal 2025?
- BIOREGENX, INC. (BRGX) reported free cash flow of $29,915 for fiscal 2025 (the year ended Dec 31, 2025), against -$513,538 the year before. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOREGENX, INC. (BRGX)'s total assets?
- As of Dec 31, 2025, BIOREGENX, INC. (BRGX) reported total assets of $410,986, against $508,535 a year earlier (-19.2%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOREGENX, INC. (BRGX)'s total liabilities?
- As of Dec 31, 2025, BIOREGENX, INC. (BRGX) reported total liabilities of $4.9 million, against $3.9 million a year earlier (+27.3%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are BIOREGENX, INC. (BRGX)'s cash and cash equivalents?
- As of Dec 31, 2025, BIOREGENX, INC. (BRGX) reported cash and cash equivalents of $69,383, against $58,404 a year earlier (+18.8%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What is BIOREGENX, INC. (BRGX)'s total debt?
- As of Dec 31, 2025, BIOREGENX, INC. (BRGX) reported total debt of $1.2 million, against $1.1 million a year earlier (+4.1%). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BRGX&period_type=annual&limit=5"Information only, not investment advice.